Zkusit zdarma
Denali Therapeutics Inc.

Denali Therapeutics Inc.

DNLI
Cena:
$ 18.64
-0.66 (-3.42%)
Valuace
70
Růst
15
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Hedge Fund Wagers $36 Million on Biotech Denali After First FDA Approval

Hedge Fund Wagers $36 Million on Biotech Denali After First FDA Approval

14:23 18-05-2026

This biotech develops therapies for neurodegenerative diseases, advancing a broad pipeline through s...

Denali Therapeutics Says AVLAYAH Launch Ahead of Expectations After Hunter Syndrome Approval

Denali Therapeutics Says AVLAYAH Launch Ahead of Expectations After Hunter Syndrome Approval

6:08 16-05-2026

Denali Therapeutics NASDAQ: DNLI is seeing early commercial interest for its first approved drug, AV...

Denali Therapeutics Inc. (DNLI) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Denali Therapeutics Inc. (DNLI) Presents at Bank of America Global Healthcare Conference 2026 Transcript

22:00 12-05-2026

Denali Therapeutics Inc. (DNLI) Presents at Bank of America Global Healthcare Conference 2026 Transc...

DNLI Q1 Loss Narrower Than Expected, Avlayah Approval Boosts Prospects

DNLI Q1 Loss Narrower Than Expected, Avlayah Approval Boosts Prospects

13:41 08-05-2026

Denali narrows its Q1 loss and gains FDA approval for Avlayah, the first new Hunter syndrome treatme...

Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights

Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights

16:01 07-05-2026

SOUTH SAN FRANCISCO, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI...

Privium Fund Opens $5.07 Million Denali Stake Ahead of FDA Drug Approval

Privium Fund Opens $5.07 Million Denali Stake Ahead of FDA Drug Approval

16:33 05-05-2026

This biotech company develops therapies for neurodegenerative and rare diseases, supported by clinic...

Denali: The First Commercial Validation Of The Blood-Brain Barrier Platform

Denali: The First Commercial Validation Of The Blood-Brain Barrier Platform

0:13 03-05-2026

Denali Therapeutics has transitioned from a speculative platform to a commercial-stage rare disease ...

DNLI Gains 25.4% Year to Date: Should You Buy, Sell or Hold the Stock?

DNLI Gains 25.4% Year to Date: Should You Buy, Sell or Hold the Stock?

14:40 17-04-2026

DNLI secures FDA nod for Avlayah, a first-in-decades Hunter syndrome therapy, but pipeline risks and...

Denali Stock Falls as Partner Takeda Ends Collaboration Deal

Denali Stock Falls as Partner Takeda Ends Collaboration Deal

15:31 07-04-2026

DNLI's shares decline after Takeda exits DNL593 partnership, leaving Denali to fully control and fun...

Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's Why

Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's Why

13:26 06-04-2026

Takeda on Friday notified Denali Therapeutics regarding the termination of their collaboration agree...

Capricorn Fund Managers Ltd Acquires New Position in Denali Therapeutics Inc. $DNLI

Capricorn Fund Managers Ltd Acquires New Position in Denali Therapeutics Inc. $DNLI

4:59 06-04-2026

Capricorn Fund Managers Ltd acquired a new stake in Denali Therapeutics Inc. (NASDAQ: DNLI) in the f...

SG Americas Securities LLC Increases Stock Position in Denali Therapeutics Inc. $DNLI

SG Americas Securities LLC Increases Stock Position in Denali Therapeutics Inc. $DNLI

4:47 05-04-2026

SG Americas Securities LLC boosted its holdings in Denali Therapeutics Inc. (NASDAQ: DNLI) by 291.6%...

Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Average Rating of “Moderate Buy” from Analysts

Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Average Rating of “Moderate Buy” from Analysts

2:35 05-04-2026

Denali Therapeutics Inc. (NASDAQ: DNLI - Get Free Report) has been given a consensus recommendation ...

Denali Wins FDA Nod for Hunter Syndrome Drug, Stock Up

Denali Wins FDA Nod for Hunter Syndrome Drug, Stock Up

15:26 26-03-2026

DNLI surges after FDA approves Avlayah, its first commercial drug and a breakthrough Hunter syndrome...

Denali Therapeutics Inc. (DNLI) Discusses FDA Approval and Commercial Launch Plans for AVLAYAH for Hunter Syndrome Transcript

Denali Therapeutics Inc. (DNLI) Discusses FDA Approval and Commercial Launch Plans for AVLAYAH for Hunter Syndrome Transcript

6:55 26-03-2026

Denali Therapeutics Inc. (DNLI) Discusses FDA Approval and Commercial Launch Plans for AVLAYAH for H...

Denali Jumps, Pulling Regenxbio Higher, On Early FDA Approval

Denali Jumps, Pulling Regenxbio Higher, On Early FDA Approval

14:08 25-03-2026

Denali Therapeutics won FDA approval Wednesday for the first new drug in 20 years to treat a rare ge...

Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)

Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)

11:50 25-03-2026

SOUTH SAN FRANCISCO, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DN...

Denali Therapeutics CEO: 2026 Pivotal With Hunter Syndrome FDA Decision and New TV Trial Readouts

Denali Therapeutics CEO: 2026 Pivotal With Hunter Syndrome FDA Decision and New TV Trial Readouts

1:02 21-03-2026

Denali Therapeutics (NASDAQ: DNLI) founder and CEO Ryan Watts said 2026 is shaping up to be a pivota...

Denali Therapeutics Inc. (DNLI) Presents at Stifel 2026 Virtual CNS Forum Transcript

Denali Therapeutics Inc. (DNLI) Presents at Stifel 2026 Virtual CNS Forum Transcript

20:22 20-03-2026

Denali Therapeutics Inc. (DNLI) Presents at Stifel 2026 Virtual CNS Forum Transcript...

Cantor Fitzgerald L. P. Makes New $653,000 Investment in Denali Therapeutics Inc. $DNLI

Cantor Fitzgerald L. P. Makes New $653,000 Investment in Denali Therapeutics Inc. $DNLI

4:35 16-03-2026

Cantor Fitzgerald L. P. acquired a new position in shares of Denali Therapeutics Inc. (NASDAQ: DNLI)...

close

DENALI THERAPEUTICS PRESENTS ENZYME TRANSPORTVEHICLE™ PROGRESS ACROSS THREE CLINICAL PROGRAMS FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS AT 2026 WORLDSYMPOSIUM™

05-02-2026
SOUTH SAN FRANCISCO, CALIF., FEB. 05, 2026 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS TO HOST WEBCAST HIGHLIGHTING PRESENTATIONS ON ENZYME TRANSPORTVEHICLE™ PROGRAMS AT THE 2026 WORLDSYMPOSIUM™

02-02-2026
SOUTH SAN FRANCISCO, CALIF., FEB. 02, 2026 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS ANNOUNCES DATA PRESENTATIONS ON ENZYME TRANSPORTVEHICLE™ PROGRAMS FOR HUNTER SYNDROME, SANFILIPPO SYNDROME TYPE A AND POMPE DISEASE AT UPCOMING 2026 WORLDSYMPOSIUM™

29-01-2026
SOUTH SAN FRANCISCO, CALIF., JAN. 29, 2026 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

THE NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES PHASE 1/2 STUDY OF DENALI THERAPEUTICS' TIVIDENOFUSP ALFA (DNL310) FOR HUNTER SYNDROME (MPS II)

30-12-2025
SOUTH SAN FRANCISCO, CALIF., DEC. 30, 2025 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

10-12-2025
SOUTH SAN FRANCISCO, CALIF., DEC. 10, 2025 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS ANNOUNCES PROPOSED OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

09-12-2025
SOUTH SAN FRANCISCO, CALIF., DEC. 09, 2025 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

ROYALTY PHARMA AND DENALI THERAPEUTICS ANNOUNCE $275 MILLION ROYALTY FUNDING AGREEMENT

04-12-2025
NEW YORK AND SOUTH SAN FRANCISCO, CALIF., DEC. 04, 2025 (GLOBE NEWSWIRE) -- ROYALTY PHARMA PLC (NASD...
Více zde

DENALI THERAPEUTICS AND ROYALTY PHARMA ANNOUNCE $275 MILLION ROYALTY FUNDING AGREEMENT

04-12-2025
SOUTH SAN FRANCISCO, CALIF. AND NEW YORK, DEC. 04, 2025 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC....
Více zde

DENALI THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

06-11-2025
SOUTH SAN FRANCISCO, CALIF., NOV. 06, 2025 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS ANNOUNCES FDA REVIEW EXTENSION OF BLA FOR TIVIDENOFUSP ALFA FOR THE TREATMENT OF MPS II (HUNTER SYNDROME)

13-10-2025
SOUTH SAN FRANCISCO, CALIF., OCT. 13, 2025 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

11-08-2025
TIVIDENOFUSP ALFA BLA FOR HUNTER SYNDROME ACCEPTED FOR PRIORITY REVIEW AND ASSIGNED PDUFA TARGET ACT...
Více zde

DENALI THERAPEUTICS ANNOUNCES FDA ACCEPTANCE AND PRIORITY REVIEW OF BIOLOGICS LICENSE APPLICATION (BLA) FOR TIVIDENOFUSP ALFA FOR HUNTER SYNDROME (MPS II)

07-07-2025
FDA ASSIGNS PDUFA TARGET ACTION DATE OF JANUARY 5, 2026, FOR DECISION ON ACCELERATED APPROVAL TIVIDE...
Více zde

DENALI THERAPEUTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS INCLUDING COMPLETION OF BLA ROLLING SUBMISSION FOR TIVIDENOFUSP ALFA FOR HUNTER SYNDROME

06-05-2025
SOUTH SAN FRANCISCO, CALIF., MAY 06, 2025 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNLI...
Více zde

DENALI THERAPEUTICS ANNOUNCES INITIATION OF BLA FILING FOR ACCELERATED APPROVAL OF TIVIDENOFUSP ALFA FOR THE TREATMENT OF HUNTER SYNDROME (MPS II) AND POSITIVE ONGOING INTERACTIONS WITH FDA ON DNL126 THROUGH START PROGRAM

02-04-2025
SOUTH SAN FRANCISCO, CALIF., APRIL 02, 2025 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DN...
Více zde

DENALI THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

27-02-2025
SOUTH SAN FRANCISCO, CALIF., FEB. 27, 2025 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS ANNOUNCES PRIMARY ANALYSIS AND LONG-TERM FOLLOW-UP OF PHASE 1/2 STUDY IN HUNTER SYNDROME (MPS II) WITH TIVIDENOFUSP ALFA

06-02-2025
SOUTH SAN FRANCISCO, CALIF., FEB. 06, 2025 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS ANNOUNCES TOPLINE RESULTS FOR REGIMEN G EVALUATING EIF2B AGONIST DNL343 IN THE PHASE 2/3 HEALEY ALS PLATFORM TRIAL

06-01-2025
SOUTH SAN FRANCISCO, CALIF., JAN. 06, 2025 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

06-11-2024
SOUTH SAN FRANCISCO, CALIF., NOV. 06, 2024 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS ANNOUNCES SUCCESSFUL MEETING WITH THE FDA AND PLANS TO FILE FOR ACCELERATED APPROVAL OF TIVIDENOFUSP ALFA (DNL310) FOR THE TREATMENT OF MPS II (HUNTER SYNDROME)

03-09-2024
SOUTH SAN FRANCISCO, CALIF., SEPT. 03, 2024 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DN...
Více zde

DENALI THERAPEUTICS ANNOUNCES PUBLICATION IN SCIENCE TRANSLATIONAL MEDICINE DEMONSTRATING THE POTENTIAL OF THE OLIGONUCLEOTIDE TRANSPORT VEHICLE PLATFORM TO ACHIEVE BROAD BIODISTRIBUTION OF ANTISENSE OLIGONUCLEOTIDES IN THE CNS AND MUSCLE FOLLOWING INTRAV

14-08-2024
SOUTH SAN FRANCISCO, CALIF., AUG. 14, 2024 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

01-08-2024
SOUTH SAN FRANCISCO, CALIF., AUG. 01, 2024 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS ANNOUNCES FDA HAS SELECTED DNL126 (ETV:SGSH) FOR MPS IIIA (SANFILIPPO SYNDROME TYPE A) FOR START PILOT PROGRAM INTENDED TO ACCELERATE DEVELOPMENT OF RARE DISEASE THERAPIES

03-06-2024
SOUTH SAN FRANCISCO, CALIF., JUNE 03, 2024 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

07-05-2024
SOUTH SAN FRANCISCO, CALIF., MAY 07, 2024 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNLI...
Více zde

DENALI THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT FOR REGIMEN G EVALUATING EIF2B AGONIST DNL343 IN THE PHASE 2/3 HEALEY ALS PLATFORM TRIAL

01-05-2024
SOUTH SAN FRANCISCO, CALIF., MAY 01, 2024 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNLI...
Více zde

DENALI THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

27-02-2024
SOUTH SAN FRANCISCO, CALIF., FEB. 27, 2024 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS ANNOUNCES $500 MILLION PRIVATE PLACEMENT EQUITY FINANCING

27-02-2024
SOUTH SAN FRANCISCO, CALIF., FEB. 27, 2024 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS ANNOUNCES NEW DATA AND EXPANSION OF ITS BLOOD-BRAIN BARRIER (BBB)-CROSSING ENZYME REPLACEMENT THERAPY PROGRAMS AT WORLDSYMPOSIUM™

07-02-2024
SOUTH SAN FRANCISCO, CALIF., FEB. 07, 2024 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS ANNOUNCES PRESENTATIONS ON ITS INVESTIGATIONAL BLOOD-BRAIN BARRIER (BBB)-CROSSING ENZYME REPLACEMENT THERAPIES AT THE UPCOMING 2024 WORLDSYMPOSIUM™

01-02-2024
SOUTH SAN FRANCISCO, CALIF., FEB. 01, 2024 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS ANNOUNCES KEY ANTICIPATED 2024 MILESTONES AND PRIORITIES TO FURTHER ADVANCE ITS THERAPEUTICS PORTFOLIO FOR NEURODEGENERATION AND LYSOSOMAL STORAGE DISEASES

08-01-2024
SOUTH SAN FRANCISCO, CALIF., JAN. 08, 2024 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

DENALI THERAPEUTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

07-11-2023
SOUTH SAN FRANCISCO, CALIF., NOV. 07, 2023 (GLOBE NEWSWIRE) -- DENALI THERAPEUTICS INC. (NASDAQ: DNL...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-06 00:00:008-KStáhnout
2025-12-10 00:00:008-KStáhnout
2025-12-04 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-10-14 01:00:008-KStáhnout
2025-10-14 00:00:008-KStáhnout
2025-08-11 01:00:008-KStáhnout
2025-08-11 01:00:0010-QStáhnout
2025-08-11 00:00:008-KStáhnout
2025-08-11 00:00:0010-QStáhnout
2025-07-07 01:00:008-KStáhnout
2025-07-07 00:00:008-KStáhnout
2025-06-03 01:00:008-KStáhnout
2025-06-03 00:00:008-KStáhnout
2025-05-06 01:00:008-KStáhnout
2025-05-06 01:00:0010-QStáhnout
2025-05-06 00:00:008-KStáhnout
2025-05-06 00:00:0010-QStáhnout
2025-04-02 01:00:008-KStáhnout
2025-04-02 00:00:008-KStáhnout
2025-03-05 00:00:008-KStáhnout
2025-03-04 23:00:008-KStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2025-01-07 00:00:008-KStáhnout
2025-01-06 23:00:008-KStáhnout
2024-11-18 00:00:008-KStáhnout
2024-11-17 23:00:008-KStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-06 00:00:0010-QStáhnout
2024-11-05 23:00:008-KStáhnout
2024-11-05 23:00:0010-QStáhnout
2024-10-10 01:00:008-KStáhnout
2024-10-10 00:00:008-KStáhnout
2024-08-01 01:00:008-KStáhnout
2024-08-01 01:00:0010-QStáhnout
2024-08-01 00:00:008-KStáhnout
2024-08-01 00:00:0010-QStáhnout
2024-05-31 01:00:008-KStáhnout
2024-05-31 00:00:008-KStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:008-KStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-02-28 00:00:0010-KStáhnout
2024-02-27 23:00:0010-KStáhnout
2024-02-27 00:00:008-KStáhnout
2024-02-26 23:00:008-KStáhnout
2024-02-16 00:00:008-KStáhnout
2024-02-15 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-08-21 01:00:008-KStáhnout
2023-08-21 00:00:008-KStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-06-20 01:00:008-KStáhnout
2023-06-20 00:00:008-KStáhnout
2023-06-05 01:00:008-KStáhnout
2023-06-05 00:00:008-KStáhnout
2023-06-02 01:00:008-KStáhnout
2023-06-02 00:00:008-KStáhnout
2023-05-08 01:00:008-KStáhnout
2023-05-08 01:00:0010-QStáhnout
2023-05-08 00:00:008-KStáhnout
2023-05-08 00:00:0010-QStáhnout
2023-02-27 00:00:008-KStáhnout
2023-02-27 00:00:0010-KStáhnout
2023-02-26 23:00:008-KStáhnout
2023-02-26 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-10-20 01:00:008-KStáhnout
2022-10-20 00:00:008-KStáhnout
2022-10-18 01:00:008-KStáhnout
2022-10-18 00:00:008-KStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-07-05 01:00:008-KStáhnout
2022-07-05 00:00:008-KStáhnout
2022-06-03 01:00:008-KStáhnout
2022-06-03 00:00:008-KStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 01:00:0010-QStáhnout
2022-05-05 00:00:008-KStáhnout
2022-05-05 00:00:0010-QStáhnout
2022-03-16 00:00:008-KStáhnout
2022-03-15 23:00:008-KStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-28 00:00:0010-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-02-27 23:00:0010-KStáhnout
2022-02-14 00:00:008-KStáhnout
2022-02-13 23:00:008-KStáhnout
2022-02-10 00:00:008-KStáhnout
2022-02-09 23:00:008-KStáhnout
2022-02-07 00:00:008-KStáhnout
2022-02-06 23:00:008-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-11-17 00:00:008-KStáhnout
2021-11-16 23:00:008-KStáhnout
2021-11-04 00:00:008-KStáhnout
2021-11-04 00:00:0010-QStáhnout
2021-11-03 23:00:008-KStáhnout
2021-11-03 23:00:0010-QStáhnout
2021-08-04 01:00:008-KStáhnout
2021-08-04 01:00:0010-QStáhnout
2021-08-04 00:00:008-KStáhnout
2021-08-04 00:00:0010-QStáhnout
2021-07-26 01:00:008-KStáhnout
2021-07-26 00:00:008-KStáhnout
2021-06-04 01:00:008-KStáhnout
2021-06-04 00:00:008-KStáhnout
2021-05-05 01:00:0010-QStáhnout
2021-05-05 00:00:0010-QStáhnout
2021-05-03 01:00:008-KStáhnout
2021-05-03 00:00:008-KStáhnout
2021-02-26 00:00:0010-KStáhnout
2021-02-25 23:00:0010-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-24 23:00:008-KStáhnout
2021-02-12 00:00:008-KStáhnout
2021-02-11 23:00:008-KStáhnout
2021-02-05 00:00:008-KStáhnout
2021-02-04 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-11-10 00:00:008-KStáhnout
2020-11-09 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-10-07 01:00:008-KStáhnout
2020-10-07 00:00:008-KStáhnout
2020-08-20 01:00:008-KStáhnout
2020-08-20 00:00:008-KStáhnout
2020-08-07 01:00:008-KStáhnout
2020-08-07 01:00:0010-QStáhnout
2020-08-07 00:00:008-KStáhnout
2020-08-07 00:00:0010-QStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 00:00:008-KStáhnout
2020-06-08 01:00:008-KStáhnout
2020-06-08 00:00:008-KStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 01:00:0010-QStáhnout
2020-05-07 00:00:008-KStáhnout
2020-05-07 00:00:0010-QStáhnout
2020-04-02 01:00:008-KStáhnout
2020-04-02 00:00:008-KStáhnout
2020-02-27 00:00:008-KStáhnout
2020-02-27 00:00:0010-KStáhnout
2020-02-26 23:00:008-KStáhnout
2020-02-26 23:00:0010-KStáhnout
2020-01-29 00:00:008-KStáhnout
2020-01-28 23:00:008-KStáhnout
2020-01-27 00:00:008-KStáhnout
2020-01-26 23:00:008-KStáhnout
2020-01-14 00:00:008-KStáhnout
2020-01-13 23:00:008-KStáhnout
2019-11-06 00:00:008-KStáhnout
2019-11-06 00:00:0010-QStáhnout
2019-11-05 23:00:008-KStáhnout
2019-11-05 23:00:0010-QStáhnout
2019-08-06 01:00:008-KStáhnout
2019-08-06 01:00:0010-QStáhnout
2019-08-06 00:00:008-KStáhnout
2019-08-06 00:00:0010-QStáhnout
2019-06-03 01:00:008-KStáhnout
2019-06-03 00:00:008-KStáhnout
2019-05-08 01:00:008-KStáhnout
2019-05-08 01:00:0010-QStáhnout
2019-05-08 00:00:008-KStáhnout
2019-05-08 00:00:0010-QStáhnout
2019-03-12 00:00:008-KStáhnout
2019-03-12 00:00:0010-KStáhnout
2019-03-11 23:00:008-KStáhnout
2019-03-11 23:00:0010-KStáhnout
2019-01-04 00:00:008-KStáhnout
2019-01-03 23:00:008-KStáhnout
2018-11-19 00:00:008-KStáhnout
2018-11-18 23:00:008-KStáhnout
2018-11-08 00:00:008-KStáhnout
2018-11-08 00:00:0010-QStáhnout
2018-11-07 23:00:008-KStáhnout
2018-11-07 23:00:0010-QStáhnout
2018-11-01 00:00:008-KStáhnout
2018-10-31 23:00:008-KStáhnout
2018-08-09 01:00:008-KStáhnout
2018-08-09 01:00:0010-QStáhnout
2018-08-09 00:00:008-KStáhnout
2018-08-09 00:00:0010-QStáhnout
2018-08-01 01:00:008-KStáhnout
2018-08-01 00:00:008-KStáhnout
2018-06-15 01:00:008-KStáhnout
2018-06-15 00:00:008-KStáhnout
2018-05-30 01:00:008-KStáhnout
2018-05-30 00:00:008-KStáhnout
2018-05-11 01:00:008-KStáhnout
2018-05-11 01:00:0010-QStáhnout
2018-05-11 00:00:008-KStáhnout
2018-05-11 00:00:0010-QStáhnout
2018-05-07 01:00:008-KStáhnout
2018-05-07 00:00:008-KStáhnout
2018-03-19 00:00:008-KStáhnout
2018-03-19 00:00:0010-KStáhnout
2018-03-18 23:00:008-KStáhnout
2018-03-18 23:00:0010-KStáhnout
2018-01-05 00:00:008-KStáhnout
2018-01-04 23:00:008-KStáhnout
2017-12-12 00:00:008-KStáhnout
2017-12-11 23:00:008-KStáhnout
preloader